Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
Juniper Biosciences has raised $40.0M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Juniper Biosciences's investors include NovaCapital.
Juniper Biosciences is headquartered in Bridgewater, United States.
Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
Juniper Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Juniper Biosciences — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/juniper-biosciences. Accessed November 15, 2026.
VCBacked. (2025). Juniper Biosciences — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/juniper-biosciences
{{cite web |title=Juniper Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/juniper-biosciences |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Juniper Biosciences? Request a listing update